ENT Oncology Practice Questions

Q: Most common site for nasopharyngeal carcinoma is:

Fossa of Rosenmuller. ***Fossa of Rosenmuller*** - The **fossa of Rosenmuller**, also known as the pharyngeal recess, is the most common site for the development of **nasopharyngeal carcinoma (NPC)**. - This anatomical location is prone to tumor development due to its complex lymphatic drainage and potential exposure to environmental factors. *Post part of Nasal cavity close to the margin of sphenopalatine foramen* - While this area is part of the nasopharynx, it is not the **predominant site** for the origin of **nasopharyngeal carcinoma (NPC)**. - Tumors originating here would be less common than those in the fossa of Rosenmuller. *Post end of septum* - The posterior end of the nasal septum is an anatomical structure in the nasopharynx but is **not a common primary site** for **nasopharyngeal carcinoma**. - Tumors are more likely to arise from the lateral walls or roof of the nasopharynx. *Lateral part of nasopharynx* - The lateral part of the nasopharynx is a general description, and while the **fossa of Rosenmuller** is located on the lateral wall, it is a **more specific and common site** for NPC. - Simply stating "lateral part" is less precise than identifying the fossa of Rosenmuller.

Q: Juvenile nasopharyngeal angiofibroma spreading to pterygomaxillary fossa is which stage?

Stage II. ***Stage II*** - This stage describes **tumor extension** to the **pterygomaxillary fossa** or maxillary, ethmoid, or sphenoid sinuses with bone destruction. - According to the **Fisch staging system** (most widely used), pterygomaxillary fossa involvement specifically defines Stage II disease. - This represents locally advanced disease beyond the nasopharynx but without infratemporal fossa or intracranial extension. *Stage III* - This stage signifies extension to the **infratemporal fossa**, **orbit**, or **parasellar region** (remaining lateral to cavernous sinus). - It represents more extensive local spread than pterygomaxillary fossa involvement alone. - Requires more complex surgical approaches and has greater morbidity. *Stage IV* - This stage indicates **intracranial extension** with involvement of the **cavernous sinus**, **optic chiasm**, or **pituitary fossa**. - It represents the most advanced disease with the highest surgical complexity and potential for complications. - Often requires combined neurosurgical approaches. *Stage I* - Stage I describes a tumor strictly confined to the **nasopharynx** and **nasal cavity** without extension to adjacent structures. - This is the earliest stage with the best prognosis and typically amenable to endoscopic resection. - No bone destruction or extension to sinuses or fossae.

Q: Which of the following is an inappropriate indication for concomitant chemotherapy in cases of head and neck cancer?

Metastatic advanced head and neck cancer. ***Metastatic advanced head and neck cancer*** - While chemotherapy is used in metastatic head and neck cancer, the term "concomitant chemotherapy" implies simultaneous administration with radiation therapy. For **metastatic disease**, the primary treatment strategy is usually **systemic chemotherapy** or targeted therapy, not necessarily concomitant with radiation to a local site with curative intent. - Concomitant chemoradiation is primarily used for **locally advanced, non-metastatic disease** to improve local control and survival, not typically for systemic metastatic disease where the goal is palliation or systemic control. *As an organ-preserving method of treatment* - Concomitant chemoradiation is a well-established strategy for organ preservation, particularly in advanced laryngeal and pharyngeal cancers, allowing patients to avoid **laryngectomy** or extensive surgical resections while achieving similar oncologic outcomes. - This approach aims to maintain **swallowing and speech function** by reducing tumor burden and eradicating microscopic disease. *Primary treatment for patients with unresectable disease* - For **unresectable locally advanced head and neck cancers**, concomitant chemoradiation is often considered the **definitive primary treatment** to achieve local control and improve survival outcomes. - Surgery is not feasible in these cases due to tumor extent or involvement of critical structures, making chemoradiation the best curative option. *Postoperative case of intermediate stage resectable tumor* - **Adjuvant concomitant chemoradiation** is indicated postoperatively for resected tumors with high-risk features such as **extracapsular extension (ECE)** or positive surgical margins, even in intermediate stages. - This is done to eradicate microscopic residual disease and reduce the risk of **local-regional recurrence**.

Q: Second primary tumor of head and neck is most commonly seen in malignancy of:

Oral cavity. ***Oral cavity*** - Patients with **oral cavity squamous cell carcinoma** (OCSCC) have the highest incidence of developing **second primary tumors** (SPTs) in the head and neck region, often due to shared risk factors like tobacco and alcohol use. - The concept of "**field cancerization**" explains this phenomenon, where prolonged exposure to carcinogens leads to widespread genetic alterations in the mucosal lining, predisposing multiple sites to develop independent primary cancers. *Paranasal sinuses* - While paranasal sinus cancers can be aggressive, they are less commonly associated with the development of **second primary tumors** within the head and neck compared to oral cavity cancers. - The etiology of paranasal sinus cancers is often linked to specific exposures like wood dust or nickel, which are less broadly distributed across the upper aerodigestive tract compared to tobacco and alcohol. *Hypopharynx* - Hypopharyngeal cancers do carry a significant risk of developing **second primary tumors**, particularly in the esophagus and lungs, but the overall incidence of head and neck SPTs is generally considered lower than that for oral cavity cancers. - The anatomical location and typical lymphatic drainage patterns of hypopharyngeal cancers might direct SPTs to different sites compared to oral cavity cancers. *Larynx* - Laryngeal cancers, especially those of the **glottis**, are also strongly associated with tobacco and alcohol. However, the incidence of **second primary tumors** in other head and neck sites is typically reported to be lower than in oral cavity cancer patients. - While laryngeal cancer patients are at risk for SPTs in the lung and esophagus, the synchronous or metachronous development of another primary tumor *within* the head and neck region is more prevalent in oral cavity cases.

Q: Most common site for nasopharyngeal carcinoma:

Fossa of Rosenmuller. ***Fossa of Rosenmuller*** - The **fossa of Rosenmuller** (also known as the pharyngeal recess) is a deep indentation located posterolateral to the opening of the **Eustachian tube** in the nasopharynx. - This area is rich in **lymphoid tissue** and is the most common site for the initial development of nasopharyngeal carcinoma, making it a critical region for examination. *Nasal septum* - The **nasal septum** is the cartilaginous and bony wall dividing the nasal cavity into two halves. - While various pathologies can affect the nasal septum, it is not a common site for the primary development of **nasopharyngeal carcinoma**. *Vault of nasopharynx* - The **vault of the nasopharynx** refers to the superior wall or roof of the nasopharynx. - Although nasopharyngeal carcinoma can spread to or involve the vault, it is not the most frequent site of **origin** compared to the fossa of Rosenmuller. *Lateral wall of nasopharynx* - The **lateral wall of the nasopharynx** contains the Eustachian tube opening and the fossa of Rosenmuller. - While the tumor is located on the lateral wall, the most specific and most common site of origin on the lateral wall is the **fossa of Rosenmuller**, making this option less precise.

Q: A 50-year-old man with a history of chronic smoking presents with persistent ear pain and a mass in the neck. What is the most likely cause?

Nasopharyngeal carcinoma. ***Nasopharyngeal carcinoma*** - This presentation, especially in a chronic smoker, strongly suggests **nasopharyngeal carcinoma**. - **Persistent ear pain** (often referred otalgia due to cranial nerve involvement) and a **neck mass** (due to metastatic lymphadenopathy) are classic symptoms. *Otosclerosis* - Characterized by **progressive conductive hearing loss** due to abnormal bone growth in the middle ear. - It does not typically present with ear pain or a neck mass, and its etiology is not linked to smoking. *Tonsillitis* - An **inflammation of the tonsils** causing sore throat, dysphagia, and sometimes fever. - It does not cause a persistent, unilateral ear pain or neck mass (unless it's a peritonsillar abscess, which is acute). *Acoustic neuroma* - A **benign tumor** of the vestibulocochlear nerve that causes **unilateral sensorineural hearing loss**, **tinnitus**, and dizziness. - It does not present with ear pain or a neck mass.

Q: Which of the following is the MOST significant independent risk factor for head and neck cancers?

Smoking. ***Smoking*** - **Smoking** is the **most significant independent risk factor** for head and neck cancers, including those of the oral cavity, pharynx, and larynx. - The carcinogens in **tobacco smoke** directly damage DNA in epithelial cells, leading to oncogenic mutations and tumor formation. - Confers a **5-25 fold increased risk** depending on duration and intensity of use. *Chronic sinus infection* - While chronic inflammation can be a risk factor for some cancers, **chronic sinus infection** is not a generally recognized or significant risk factor for head and neck squamous cell carcinomas. - Inflammation from chronic sinusitis is typically localized to the paranasal sinuses and does not directly induce carcinogenesis in the broader head and neck region. *Alcohol consumption* - **Alcohol consumption** is also a significant independent risk factor for head and neck cancers (relative risk 2-6x). - However, **smoking remains the strongest single risk factor**, with higher relative risk and more direct carcinogenic effects. - Alcohol acts synergistically with smoking, and their combined use increases risk 50-100 fold. *None of the options* - This option is incorrect because **smoking** is the most well-established and significant risk factor for head and neck cancers.

Q: What is the most significant factor associated with the causation of head and neck carcinoma?

Tobacco use. ***Tobacco use*** [1] - Tobacco use is the most significant risk factor for head and neck carcinomas, with strong evidence linking it to both oral and pharyngeal cancers. [1] - It promotes carcinogenic changes in the mucosal lining of the head and neck, significantly increasing the risk of malignancy. [1] *History of syphilis* - While syphilis has been linked to oropharyngeal squamous cell carcinoma, its role is less significant than tobacco. - Other factors, such as HPV infection, are more clinically relevant for head and neck cancers associated with syphilis. [1] *Exposure to nickel* - Nickel exposure is primarily associated with respiratory cancers, particularly lung cancer, rather than head and neck cancers. - The connection to head and neck carcinoma is not well established, making it a minor risk factor compared to tobacco. *Intravenous drug abuse* - Although intravenous drug abuse may lead to other health complications, it is not a direct significant risk factor for head and neck carcinoma. - Other lifestyle choices and exposures, particularly tobacco, play a much larger role in the development of these cancers.

Question 1

Most common site for nasopharyngeal carcinoma is:

Accepted Answer

Fossa of Rosenmuller

Answer

Posterior end of septum

Answer

Lateral part of nasopharynx

Answer

Posterior part of nasal cavity close to the margin of sphenopalatine foramen

Question 2

Juvenile nasopharyngeal angiofibroma spreading to pterygomaxillary fossa is which stage?

Accepted Answer

Stage II

Answer

Stage IV

Answer

Stage III

Answer

Stage I

Question 3

Which of the following is an inappropriate indication for concomitant chemotherapy in cases of head and neck cancer?

Accepted Answer

Metastatic advanced head and neck cancer

Answer

As an organ-preserving method of treatment

Answer

Primary treatment for patients with unresectable disease

Answer

Postoperative case of intermediate stage resectable tumor

Question 4

Second primary tumor of head and neck is most commonly seen in malignancy of:

Accepted Answer

Oral cavity

Answer

Paranasal sinuses

Answer

Hypopharynx

Answer

Larynx

Question 5

Most common site for nasopharyngeal carcinoma:

Accepted Answer

Fossa of Rosenmuller

Answer

Nasal septum

Answer

Vault of nasopharynx

Answer

Lateral wall of nasopharynx

Question 6

A 50-year-old man with a history of chronic smoking presents with persistent ear pain and a mass in the neck. What is the most likely cause?

Accepted Answer

Nasopharyngeal carcinoma

Answer

Otosclerosis

Answer

Tonsillitis

Answer

Acoustic neuroma

Question 7

Which of the following is the MOST significant independent risk factor for head and neck cancers?

Accepted Answer

Smoking

Answer

Chronic sinus infection

Answer

Alcohol consumption

Answer

None of the options

Question 8

What is the most significant factor associated with the causation of head and neck carcinoma?

Accepted Answer

Tobacco use

Answer

Intravenous drug abuse

Answer

Exposure to nickel

Answer

History of syphilis

ENT Oncology — MCQs

ENT Oncology — MCQs

On this page

Practice by Chapter

Want unlimited practice?